BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 15172630)

  • 21. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
    Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low density lipoprotein apheresis in pediatric patients with homozygous familial hypercholesterolemia.
    Coker M; Ucar SK; Simsek DG; Darcan S; Bak M; Can S
    Ther Apher Dial; 2009 Apr; 13(2):121-8. PubMed ID: 19379151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-density lipoprotein apheresis therapy with a direct hemoperfusion column: a Japanese multicenter clinical trial.
    Tasaki H; Yamashita K; Saito Y; Bujo H; Daida H; Mabuchi H; Tominaga Y; Matsuzaki M; Fukunari K; Nakazawa R; Tsuji M; Kawade Y; Yamamoto S; Ueda Y; Takayama K
    Ther Apher Dial; 2006 Feb; 10(1):32-41. PubMed ID: 16556134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Non-dietary, non-pharmacological treatment of severe hypercholesterolemia].
    Hansen PS; Sølling J; Knudsen TE; Faergeman O
    Ugeskr Laeger; 1991 Jul; 153(29):2046-51. PubMed ID: 1858184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of LDL-apheresis--more than reduction of cholesterol?].
    Schettler V; Wieland E
    Dtsch Med Wochenschr; 2007 Mar; 132(11):575-8. PubMed ID: 17342636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [An apheresis method in treatment of familial hypercholesterolemia].
    Derfler K
    Wien Klin Wochenschr; 2000 Jan; 112(2):49-51. PubMed ID: 10703150
    [No Abstract]   [Full Text] [Related]  

  • 27. [LDL-apheresis in the treatment of familial hypercholesterolemia].
    Scarpato N; Postiglione A
    Ric Clin Lab; 1985; 15 Suppl 1():499-504. PubMed ID: 4035229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential indication of lipoprotein apheresis during pregnancy.
    Klingel R; Göhlen B; Schwarting A; Himmelsbach F; Straube R
    Ther Apher Dial; 2003 Jun; 7(3):359-64. PubMed ID: 12924613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid apheresis applications in childhood: experience in the University Hospital of Gazi.
    Eminoglu TF; Yenicesu I; Tumer L; Okur I; Dilsiz G; Hasanoglu A
    Transfus Apher Sci; 2008 Dec; 39(3):235-40. PubMed ID: 18955012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrospective analysis of long-term lipid apheresis at a single center.
    Koziolek MJ; Hennig U; Zapf A; Bramlage C; Grupp C; Armstrong VW; Strutz F; Müller GA
    Ther Apher Dial; 2010 Apr; 14(2):143-52. PubMed ID: 20438535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [LDL-apheresis: current status].
    Stefanutti C; Vivenzio A; Lucani G; Di Giacomo S
    Clin Ter; 2001; 152(1):65-9. PubMed ID: 11382172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effects of LDL apheresis in patients with severe hypercholesterolemia.
    Sachais BS; Katz J; Ross J; Rader DJ
    J Clin Apher; 2005 Dec; 20(4):252-5. PubMed ID: 15880364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Apheresis in severe hypercholesterolaemia].
    Graesdal A; Hovland A; Bjørbaek E
    Tidsskr Nor Laegeforen; 2004 Apr; 124(8):1085-7. PubMed ID: 15114383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current view: indications for extracorporeal lipid apheresis treatment.
    Schettler V; Neumann CL; Hulpke-Wette M; Hagenah GC; Schulz EG; Wieland E;
    Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):15-9. PubMed ID: 22528134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis--comparison of performance characteristics with DALI and Lipidfiltration.
    Julius U; Parhofer KG; Heibges A; Kurz S; Klingel R; Geiss HC
    J Clin Apher; 2007; 22(4):215-23. PubMed ID: 17455220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of lipid apheresis in changing times.
    Schuff-Werner P; Fenger S; Kohlschein P
    Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):7-14. PubMed ID: 22911176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of LDL-immunoapheresis on plasma concentrations of vitamin E and carotenoids in patients with familial hypercholesterolemia.
    Cauza E; Jansen M; Resch U; Dunky A; Derfler K; Winklhofer-Roob BM; Kostner K
    J Clin Apher; 2004; 19(4):174-9. PubMed ID: 15597350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homozygous familial hypercholesterolaemia and treatment by LDL apheresis.
    King RI; Scott RS; Florkowski CM; Laurie AD; Reid N; George PM
    N Z Med J; 2010 Jul; 123(1319):79-82. PubMed ID: 20717180
    [No Abstract]   [Full Text] [Related]  

  • 39. From plasma-exchange to LDL-apheresis: new developments in the treatment of familial hypercholesterolemia.
    Postiglione A; Gnasso A; Mastranzo P; Montefusco S; Motti C; Gallotta G; Cortese C; Scarpato N
    Beitr Infusionsther; 1988; 23():74-80. PubMed ID: 2484784
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term efficacy of lipoprotein apheresis in the management of familial hypercholesterolaemia: Application of two different apheresis techniques in childhood.
    Gokay S; Kendirci M; Kaynar L; Solmaz M; Cetin A; Kardas F; Soylu Ustkoyuncu P
    Transfus Apher Sci; 2016 Apr; 54(2):282-8. PubMed ID: 26577019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.